Pharma giant Roche just made a $2.4 billion bet on cancer data (FMI)
|06/19/2018||Posted by BusinessMediaguide.Com under General World News||
- Roche on Tuesday bought the rest of Foundation Medicine, a company that collects genetic data from samples of cancer tissue or blood, for $2.4 billion.
- Roche had held a majority stake in the company, and the deal values Foundation at $5.3 billion.
- In February, Roche scooped up Flatiron Health, another company gathering cancer data that often works with Foundation, for $1.9 billion.
Roche just made another big bet on cancer data.
On Tuesday, the Swiss pharma giant acquired the rest of Foundation Medicine, a company that sequences the genetics of a person’s tumor, for $2.4 billion.
Roche had held a majority stake in read more >>>